Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study
Poordad, F, Bennett, M, Sepe, T.E, Cohen, E, Reindollar, R.W, Everson, G, Phillips, R.W, Siddique, A, Sullivan, J.G, Box, T.D, Fu, B, Pilot-Matias, T, Abunimeh, M, Cohen, D.E, Younes, Z
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
High Efficacy of Abt-493 and Abt-530 in Hcv Genotype 1 Infected Patients who Have Failed Direct-Acting Antiviral-Containing Regimens: The Magellan-I Study
Poordad, F, Gordon, S.C, Asatryan, A, Felizarta, F, Reindollar, R.W, Landis, C, Fried, M.W, Bernstein, D.E, Ng, T.I, Lin, C.-W, Liu, R, Kort, J, Mensa, F.J
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure
Poordad, F, Pol, S, Asatryan, A, Buti, M, Shaw, D, Hézode, C, Lalezari, J, Felizarta, F, Reindollar, R.W, Gordon, S.C, Pianko, S, Fried, M.W, Bernstein, D.E, Gallant, J, Lin, C.-W, Lei, Y, Ng, T.I, Pilot-Matias, T, Kort, J, Mensa, F
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
GS11 - High Efficacy of Abt-493 and Abt-530 in Hcv Genotype 1 Infected Patients who Have Failed Direct-Acting Antiviral-Containing Regimens: The Magellan-I Study
Poordad, F., Gordon, S.C., Asatryan, A., Felizarta, F., Reindollar, R.W., Landis, C., Fried, M.W., Bernstein, D.E., Ng, T.I., Lin, C.-W., Liu, R., Kort, J., Mensa, F.J.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
SAT-156 - Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study
Poordad, F., Bennett, M., Sepe, T.E., Cohen, E., Reindollar, R.W., Everson, G., Phillips, R.W., Siddique, A., Sullivan, J.G., Box, T.D., Fu, B., Pilot-Matias, T., Abunimeh, M., Cohen, D.E., Younes, Z.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
PS-156 - MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure
Poordad, F., Pol, S., Asatryan, A., Buti, M., Shaw, D., Hézode, C., Lalezari, J., Felizarta, F., Reindollar, R.W., Gordon, S.C., Pianko, S., Fried, M.W., Bernstein, D.E., Gallant, J., Lin, C.-W., Lei, Y., Ng, T.I., Pilot-Matias, T., Kort, J., Mensa, F.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article